{"id":"W2038900287","doi":"10.1097/qai.0b013e3181cae4a1","title":"Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico","year":2010,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institute on Drug Abuse","keywords":"Lopinavir/ritonavir; Efavirenz; Lopinavir; Medicine; Ritonavir; Lamivudine; Internal medicine; Confidence interval; Viral load; Gastroenterology; Randomized controlled trial; Clinical endpoint; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002495922,0.001518481,0.002292418,0.0003473226,0.0006021791,0.00119359,0.00123937,0.001878625,0.007219498],"category_scores_gemma":[0.002388529,0.0009018063,0.001545282,0.0003775003,0.00139414,0.0007164253,0.0004685538,0.002075197,0.0008373672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001092995,"about_ca_system_score_gemma":0.001744955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003267386,"about_ca_topic_score_gemma":0.005491206,"domain_scores_codex":[0.9987506,0.0008811811,0.00005739171,0.0001444357,0.00005040606,0.0001160354],"domain_scores_gemma":[0.9980152,0.000611388,0.0006569352,0.0001316086,0.0001183324,0.0004664287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.988157,0.004775621,0.001154238,0.0001510125,0.0003965069,0.00001829457,0.00002776469,0.0001347224,0.000742734,0.00003322194,0.0002391836,0.004169648],"study_design_scores_gemma":[0.9539841,0.04236675,0.002699864,0.00002042512,0.0002813786,0.00001466299,0.00002015235,0.0001948173,0.0001269623,0.00002696219,0.0002583117,0.000005755997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990972,0.002141363,0.0004354629,0.0006226248,0.0003117754,0.003278276,0.000953437,0.00006508461,0.001219963],"genre_scores_gemma":[0.988934,0.001795504,0.001555313,0.0008767139,0.000402169,0.003420595,0.00135865,0.00001649896,0.001640548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007219498,"threshold_uncertainty_score":0.02415162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01787101026118139,"score_gpt":0.2887138184398692,"score_spread":0.2708428081786878,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}